CDXS Logo

Codexis, Inc. (CDXS) 

NASDAQ
Market Cap
$429.67M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
86 of 960
Rank in Industry
66 of 550

Largest Insider Buys in Sector

CDXS Stock Price History Chart

CDXS Stock Performance

About Codexis, Inc.

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance …

Insider Activity of Codexis, Inc.

Over the last 12 months, insiders at Codexis, Inc. have bought $3.82M and sold $0 worth of Codexis, Inc. stock.

On average, over the past 5 years, insiders at Codexis, Inc. have bought $1.99M and sold $4.14M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $22.94M.

The last purchase of 25,000 shares for transaction amount of $72,720 was made by Opaleye Management Inc. (10 percent owner) on 2024‑10‑25.

List of Insider Buy and Sell Transactions, Codexis, Inc.

2024-10-25Purchase10 percent owner
25,000
0.0311%
$2.91$72,7200.00%
2024-09-25Purchase10 percent owner
5,000
0.0069%
$2.86$14,291+8.46%
2024-09-24Purchase10 percent owner
80,000
0.1134%
$2.94$234,856+5.60%
2024-09-23Purchase10 percent owner
45,000
0.064%
$2.94$132,485+37.67%
2024-09-20Purchase10 percent owner
1.05M
1.4443%
$3.01$3.18M+29.52%
2024-09-18Purchase10 percent owner
61,000
0.0875%
$3.16$192,992+26.85%
2023-11-15Saledirector
20,000
0.0289%
$2.11$42,168+47.86%
2023-09-11PurchaseChief Operating Officer
9,000
0.0126%
$1.72$15,479+64.20%
2023-09-08PurchaseSee Remarks
58,479
0.0841%
$1.73$100,952+68.31%
2023-09-08PurchaseChief Financial Officer
11,650
0.0165%
$1.70$19,856+68.31%
2023-09-08PurchaseSee Remarks
11,834
0.0167%
$1.70$20,065+68.31%
2023-04-18Saledirector
35,714
0.0539%
$4.14$147,874-34.74%
2023-04-17Saledirector
35,714
0.0529%
$4.24$151,377-37.44%
2023-03-16Saledirector
35,714
0.054%
$4.11$146,681-34.04%
2023-03-15Saledirector
35,714
0.0533%
$4.09$146,131-34.62%
2023-03-08SaleSee Remarks
26,987
0.0411%
$4.56$122,931-40.09%
2023-03-08SaleChief Operating Officer
8,258
0.0126%
$4.56$37,617-40.09%
2023-03-08SaleSee remarks
7,686
0.0117%
$4.56$35,011-40.09%
2023-03-07SaleSee Remarks
28,088
0.0426%
$4.60$129,281-40.87%
2023-03-07SaleChief Operating Officer
8,596
0.013%
$4.60$39,565-40.87%

Insider Historical Profitability

9.71%
Opaleye Management Inc.10 percent owner
8545000
10.5004%
$5.2860
NICOLS JOHN Jdirector
783965
0.9634%
$5.28431<0.0001%
DILLY STEPHEN GEORGESee Remarks
438878
0.5393%
$5.2812
SHAW ALANPresident and CEO
202000
0.2482%
$5.28112+25.75%
Ryali SriramChief Financial Officer
123441
0.1517%
$5.2810

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$23.09M9.386.61M-8.08%-$2.03M<0.01
Nantahala Capital Management Llc$15.57M6.324.46M-2.85%-$457,277.240.73
Fidelity Investments$15.47M6.284.43M+1.54%+$234,447.73<0.01
The Vanguard Group$14.86M6.044.26M+3.14%+$452,907.76<0.0001
Baillie Gifford Co$12.02M4.883.45M+0.77%+$91,493.840.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.